BioHarvest Sciences Q4 Earnings Call Highlights [Yahoo! Finance]
BioHarvest Sciences Inc. (BHST)
Company Research
Source: Yahoo! Finance
margin near 59%; adjusted EBITDA was positive $0.5 million and cash rose to $23 million from $2.4 million a year earlier. VINIA remains the D2C growth engine—about 80% of sales come from vinia.com with 90% subscription revenue and 85,000 active users—and the new Blood Flow Hydration product has quickly become a top contributor to new-customer sales with strong ratings as the company shifts marketing from TV to digital to attract younger cohorts. CDMO momentum: roughly $2 million of third-party CDMO revenue in 2025 (about $9 million including internal work), four active third-party programs (including saffron, Tate & Lyle and a fragrance project), a stage-one fragrance breakthrough (stable cell culture), and guidance of $4–6 million external CDMO revenue for 2026 with potential manufacturing scale contributions by H2 2027. Interested in BioHarvest Sciences Inc.? Here are five stocks we like better. BioHarvest Sciences (NASDAQ:BHST) reported fourth-quarter revenue of $9.1 millio
Show less
Read more
Impact Snapshot
Event Time:
BHST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHST alerts
High impacting BioHarvest Sciences Inc. news events
Weekly update
A roundup of the hottest topics
BHST
News
- BioHarvest Sciences Inc. (BHST) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- BioHarvest Sciences Inc (BHST) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]Yahoo! Finance
- BioHarvest Sciences achieves revenue gains and margin expansion, narrows losses in 2025 [Yahoo! Finance]Yahoo! Finance
- BioHarvest Sciences (BHST) had its "sell (d-)" rating reaffirmed by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- BioHarvest appoints former Israeli health chief Hezi Levy to board [Yahoo! Finance]Yahoo! Finance
BHST
Earnings
- 3/31/26 - Miss
BHST
Sec Filings
- 3/31/26 - Form 40-F
- 3/27/26 - Form 6-K
- 3/17/26 - Form 6-K
- BHST's page on the SEC website